Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.
Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations
The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.
EVEN MORE SEMINARS
Rosanne Tyas Royal Hospital for Neuro-disability
Music Therapy has much to offer: An overview of the effects of music therapy across different domains in neuro-disability.
Andrew Bateman PhD MCSP University of Essex, School of Health and Social Care
Neuropsychological Rehabilitation Research: how to win funds and change services
The role of cannabis in neurology
Dr. Stephen Barabas K-Laser UK Ltd
Class IV Therapy Laser for Neurorehabilitation and Pain Management
Dr Ines Violante University of Surrey
Multimodal brain stimulation in brain injury